BRADSHER NEAL C 4

4 · BIOTIME INC · Filed Jul 3, 2019

Form 4

Period: 2019-07-01

10% Owner

Transactions

Award
OPTION TO PURCHASE COMMON SHARES
2019-07-01+40,000→ 40,000 total
Exercise: $1.03From: 2019-07-01Exp: 2029-06-30→ COMMON SHARES (40,000 underlying)

Holdings

OPTION TO PURCHASE COMMON SHARES
Exercise: $2.06From: 2019-06-30Exp: 2023-06-30→ COMMON SHARES (49,440 underlying)
49,440
OPTION TO PURCHASE COMMON SHARES
Exercise: $2.72From: 2018-07-03Exp: 2021-06-30→ COMMON SHARES (24,720 underlying)
24,720
OPTION TO PURCHASE COMMON SHARES
Exercise: $3.15From: 2018-07-03Exp: 2022-06-30→ COMMON SHARES (24,720 underlying)
24,720
OPTION TO PURCHASE COMMON SHARES
Exercise: $3.57From: 2018-07-03Exp: 2020-06-30→ COMMON SHARES (24,720 underlying)
24,720

Footnotes (5)

[F1]These options will vest and become exercisable on June 30, 2020, provided, that Neal C. Bradsher remains a member of the issuer's board of directors on that date.
[F2]The options were granted to Neal Bradsher by the issuer on July 1, 2019 as director compensation pursuant to resolutions from the minutes of the issuer's board of directors meeting on January 24, 2018.
[F3]These options are currently exercisable.
[F4]On November 28, 2018, the issuer distributed to its shareholders approximately 12.7 million shares of common stock of AgeX Therapeutics, Inc. ("AgeX") in the ratio of one share of AgeX common stock for every 10 common shares of the issuer owned by its shareholders (the "AgeX Distribution"). Pursuant to the AgeX Distribution, the issuer adjusted the amount of options held by its directors. In particular, the 40,000 options expiring on June 30, 2023 that were previously granted to Neal C. Bradsher were increased to 49,440 to reflect the AgeX Distribution.
[F5]Pursuant to the AgeX Distribution, (i) the 20,000 options expiring on June 30, 2022 that were previously granted to Neal C. Bradsher were increased to 24,720, (ii) the 20,000 options expiring on June 30, 2021 that were previously granted to Neal C. Bradsher were increased to 24,720, and (iii) the 20,000 options expiring on June 30, 2020 that were previously granted to Neal C. Bradsher were increased to 24,720.

Documents

1 file